In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge. Share this image on your social media platforms to spread the news.
Recommended Content:
COVID-19 Treatment
News Around the Military Health System
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: February 23, 2022